ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Allergic Rhinitis
Pulmonary Eosinophilia
Rhinitis
Dust Mite Allergy
Lung Diseases
Chronic Obstructive Pulmonary Disease
Respiratory Tract Diseases

Asthma trials near Chicago, IL, USA:

Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (PANDA)

This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Chicago, Illinois, United States and 7 other locations

The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...

Enrolling
Severe Asthma
Drug: Placebo
Drug: GB-0895

Phase 3

Generate Biomedicines

Glenview, Illinois, United States and 34 other locations

Locations recently updated

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Chicago, Illinois, United States and 335 other locations

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...

Active, not recruiting
Asthma
Biological: NSI-8226
Biological: Placebo

Phase 2

Uniquity One (UNI)

Winfield, Illinois, United States and 70 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Skokie, Illinois, United States and 133 other locations

Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...

Not yet enrolling
Severe Asthma
Drug: Placebo
Drug: Frevecitinib

Phase 2

Kinaset Therapeutics

Chicago, Illinois, United States and 15 other locations

The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....

Active, not recruiting
Asthma
Drug: BDA MDI HFO 160/180 μg
Drug: BDA MDI HFA 160/180 μg

Phase 3

AstraZeneca
AstraZeneca

River Forest, Illinois, United States and 127 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Glenview, Illinois, United States and 83 other locations

The goal of this observational study is to learn more about the effectiveness of benralizumab (Fasenra, 30 mg every 8 weeks) in maintaining asthma...

Begins enrollment this month
Severe Eosinophilic Asthma
Severe Asthma
Drug: Benralizumab
Drug: Budesonide-albuterol

Phase 4

Endeavor Health

Skokie, Illinois, United States

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Chicago, Illinois, United States and 74 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems